Table 3.
Proinflammatory Cytokines | Non-T2D Patients (n = 16) | Patients with T2D (n = 20) | p-Value |
---|---|---|---|
IFN-γ | 3.80 ± 2.67 | 3.41 ± 2.15 | 0.98 |
IL-1β | 0.07 ± 0.07 | 0.09 ± 0.10 | 0.86 |
IL-6 | 0.99 ± 0.49 | 1.07 ± 0.94 | 0.35 |
TNF-α | 2.00 ± 0.36 | 2.71 ± 1.25 | 0.03 * |
Plasma concentrations (pg·mL−1) of proinflammatory cytokines are presented as mean ± SD. * p < 0.05. Non-T2D, non-diabetic control patient group. T2D, patients with type 2 diabetes group. IFN-γ, interferon-gamma. IL-1β, interleukine-1beta. IL-6, interleukine-6. TNF-α, tumor necrosis factor alpha.